Literature DB >> 10383130

The transcriptional activities of p53 and its homologue p51/p63: similarities and differences.

A Shimada1, S Kato, K Enjo, M Osada, Y Ikawa, K Kohno, M Obinata, R Kanamaru, S Ikawa, C Ishioka.   

Abstract

p51/p63 is a novel p53 homologue that has been shown to act as a transcriptional activator through the p53-binding sequence of the p21/WAF1 promoter and to induce apoptosis when it is expressed transiently in a human tumor cell line. We developed transcription assay systems for these two related genes in both Saccharomyces cerevisiae and mammalian cells and used them to investigate the functional similarities and differences of these genes. We found that p51/p63 trans-activated the previously identified p53 target genes, but the degree of the transactivation by p51/p63 differed from that by p53. These results suggest that the cellular signal on p51/p63 cross-talks partially but not completely with that of the p53 pathway.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383130

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Phospho-ΔNp63α/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure.

Authors:  Yiping Huang; Alice Y Chuang; Edward A Ratovitski
Journal:  Cell Cycle       Date:  2011-11-15       Impact factor: 4.534

Review 2.  p63 and p73, the ancestors of p53.

Authors:  V Dötsch; F Bernassola; D Coutandin; E Candi; G Melino
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-05-19       Impact factor: 10.005

3.  Differential recognition of response elements determines target gene specificity for p53 and p63.

Authors:  Motonobu Osada; Hannah Lui Park; Yuichi Nagakawa; Keishi Yamashita; Alexey Fomenkov; Myoung Sook Kim; Guojun Wu; Shuji Nomoto; Barry Trink; David Sidransky
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

4.  A p53-type response element in the GDF15 promoter confers high specificity for p53 activation.

Authors:  Motonobu Osada; Hannah Lui Park; Min Joo Park; Jun-Wei Liu; Guojun Wu; Barry Trink; David Sidransky
Journal:  Biochem Biophys Res Commun       Date:  2007-01-25       Impact factor: 3.575

5.  Regulation of p53 family member isoform DeltaNp63alpha by the nuclear factor-kappaB targeting kinase IkappaB kinase beta.

Authors:  Aditi Chatterjee; Xiaofei Chang; Tanusree Sen; Rajani Ravi; Atul Bedi; David Sidransky
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

6.  Regulation of VDR by deltaNp63alpha is associated with inhibition of cell invasion.

Authors:  Ramakrishna Kommagani; Mary K Leonard; Stefanie Lewis; Rose-Anne Romano; Satrajit Sinha; Madhavi P Kadakia
Journal:  J Cell Sci       Date:  2009-07-21       Impact factor: 5.285

7.  Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumours.

Authors:  Marco Chilosi; Alberto Zamò; Antonietta Brighenti; Giorgio Malpeli; Licia Montagna; Paola Piccoli; Serena Pedron; Maurizio Lestani; Giorgio Inghirami; Aldo Scarpa; Claudio Doglioni; Fabio Menestrina
Journal:  Virchows Arch       Date:  2003-07-08       Impact factor: 4.064

8.  ATM kinase is a master switch for the Delta Np63 alpha phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damage.

Authors:  Yiping Huang; Tanusree Sen; Jatin Nagpal; Sunil Upadhyay; Barry Trink; Edward Ratovitski; David Sidransky
Journal:  Cell Cycle       Date:  2008-09-15       Impact factor: 4.534

9.  Differential effects of p63 mutants on transactivation of p53 and/or p63 responsive genes.

Authors:  Shama K Khokhar; Ramakrishna Kommagani; Madhavi P Kadakia
Journal:  Cell Res       Date:  2008-10       Impact factor: 25.617

10.  Pattern of p63 expression in squamous cell carcinoma of the oral cavity.

Authors:  Maria P Foschini; Alessia Gaiba; Roberto Cocchi; Maria G Pennesi; Maria R Gatto; Giovanni P Frezza; Annalisa Pession
Journal:  Virchows Arch       Date:  2004-03-02       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.